ReviewMaterials today. Bio2026
Versatile metal-phenolic network structure (MPNs) as advanced delivery platforms for bioactive compounds: The design principles, foundations, applications, and future perspectives.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite possessing many important functions, the applications of bioactive compounds (BCs) are significantly limited due to various inherent shortcomings. In recent years, a novel class of materials known as metal-phenolic network structures (MPNs) has emerged. As the application scope of MPNs expands, it has become evident that this network structure can protect encapsulated active substances from adverse external environmental influences. This review first introduces the types and properties of polyphenols and metal ions, as well as the basis of their interactions. Subsequently, the construction methods of MPNs and their advantages as delivery platforms for BCs are discussed, including stimuli-responsive properties, adsorption properties, UV resistance, antioxidant activity, and antimicrobial effects. The mechanisms involved in the loading of BCs into MPNs and their novel applications in nanoparticles, films, coatings, capsules, emulsions, and hydrogels are elucidated. Additionally, the safety of MPNs and their fate within the human body are addressed. The role of artificial intelligence in advancing the development of MPNs as delivery platforms for BCs is also described in detail. Finally, the advantages, limitations, and obstacles to the clinical transformation of MPNs as delivery platforms are discussed. This review aims to uncover the significant role of MPNs in delivering BCs, thereby promoting the development of MPNs and the broader application of BCs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.